Macrophage CD14 expression in human carotid plaques is associated with complicated lesions, correlates with thrombosis, and is reduced by angiotensin receptor blocker treatment

International Immunopharmacology

Volumn 22, Issue 2, 2014, Pages 318-323

  Hermansson, Cecilia ^a   Lundqvist, Annika ^a   Magnusson, Lisa U ^a   Ullström, Christina ^a   Bergström, Göran ^a   Hultén, Lillemor Mattsson ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiotensin receptor blocker; Carotid plaques; CD14; Lipopolysaccharides; Macrophages; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; CD14 ANTIGEN; CD68 ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; C REACTIVE PROTEIN; CD68 ANTIGEN, HUMAN; CYTOKINE; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

AGED; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY THROMBOSIS; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SERUM; SYMPTOM; BLOOD; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MIDDLE AGED; THROMBOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; C-REACTIVE PROTEIN; CAROTID STENOSIS; CYTOKINES; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MIDDLE AGED; RECEPTOR, ANGIOTENSIN, TYPE 1; THROMBOSIS;

EID: 84905495007     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.07.009     Document Type: Article

References (28)

1. O. Koren, A. Spor, J. Felin, F. Fak, J. Stombaugh, and V. Tremaroli et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis Proc Natl Acad Sci U S A 108 Suppl. 1 2011 4592 4598
2. Y.I. Miller, S. Viriyakosol, D.S. Worrall, A. Boullier, S. Butler, and J.L. Witztum Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages Arterioscler Thromb Vasc Biol 25 2005 1213 1219 (Pubitemid 40776611)
3. K.A. Ryan, M.F. Smith Jr., M.K. Sanders, and P.B. Ernst Reactive oxygen and nitrogen species differentially regulate toll-like receptor 4-mediated activation of nf-kappa b and interleukin-8 expression Infect Immun 72 2004 2123 2130 (Pubitemid 38419925)
4. N. de Bont, M.G. Netea, C. Rovers, T. Smilde, P.N. Demacker, and J.W. van der Meer et al. Lps-induced cytokine production and expression of lps-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of hmg-coa reductase inhibitors Atherosclerosis 139 1998 147 152 (Pubitemid 28341877)
5. S.W. Waldo, Y. Li, C. Buono, B. Zhao, E.M. Billings, and J. Chang et al. Heterogeneity of human macrophages in culture and in atherosclerotic plaques Am J Pathol 172 2008 1112 1126 (Pubitemid 351520007)
6. B. Schieffer, E. Schieffer, D. Hilfiker-Kleiner, A. Hilfiker, P.T. Kovanen, and M. Kaartinen et al. Expression of angiotensin ii and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability Circulation 101 2000 1372 1378 (Pubitemid 30169857)
7. C. Savoia, D. Burger, N. Nishigaki, A. Montezano, and R.M. Touyz Angiotensin ii and the vascular phenotype in hypertension Expert Rev Mol Med 13 2011 e11
8. A. Durante, G. Peretto, A. Laricchia, F. Ancona, M. Spartera, and A. Mangieri et al. Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis Curr Pharm Des 18 2012 981 1004
9. Y. Suzuki, M. Ruiz-Ortega, O. Lorenzo, M. Ruperez, V. Esteban, and J. Egido Inflammation and angiotensin ii Int J Biochem Cell Biol 35 2003 881 900 (Pubitemid 36379329)
10. E. Sanchez-Lemus, J. Benicky, J. Pavel, and J.M. Saavedra In vivo angiotensin ii at1 receptor blockade selectively inhibits lps-induced innate immune response and acth release in rat pituitary gland Brain Behav Immun 23 2009 945 957
11. Mrc european carotid surgery trial: Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European carotid surgery trialists' collaborative group Lancet 337 1991 1235 1243
12. C. Vijil, C. Hermansson, A. Jeppsson, G. Bergstrom, and L.M. Hulten Arachidonate 15-lipoxygenase enzyme products increase platelet aggregation and thrombin generation PLoS One 9 2014 e88546
13. H.C. Stary, A.B. Chandler, R.E. Dinsmore, V. Fuster, S. Glagov, and W. Insull Jr. et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, american heart association Arterioscler Thromb Vasc Biol 15 1995 1512 1531
14. L. Mattsson, G. Bondjers, and O. Wiklund Isolation of cell populations from arterial tissue, using monoclonal antibodies and magnetic microspheres Atherosclerosis 89 1991 25 34
15. A.P. Reiner, E.M. Lange, N.S. Jenny, P.H. Chaves, J. Ellis, and J. Li et al. Soluble cd14: Genomewide association analysis and relationship to cardiovascular risk and mortality in older adults Arterioscler Thromb Vasc Biol 33 2013 158 164
16. M. Kaito, S. Araya, Y. Gondo, M. Fujita, N. Minato, and M. Nakanishi et al. Relevance of distinct monocyte subsets to clinical course of ischemic stroke patients PLoS One 8 2013 e69409
17. S.D. Wright, R.A. Ramos, P.S. Tobias, R.J. Ulevitch, and J.C. Mathison Cd14, a receptor for complexes of lipopolysaccharide (lps) and lps binding protein Science 249 1990 1431 1433
18. D.A. Kanhai, F.L.J. Visseren, Y. van der Graaf, A.H. Schoneveld, L.M. Catanzariti, and L. Timmers et al. Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease Int J Cardiol 168 2013 2358 2363
19. X. Urra, N. Villamor, S. Amaro, M. Gomez-Choco, V. Obach, and L. Oleaga et al. Monocyte subtypes predict clinical course and prognosis in human stroke J Cereb Blood Flow Metab 29 2009 994 1002
20. M.P. Kim, M. Zhou, and L.M. Wahl Angiotensin ii increases human monocyte matrix metalloproteinase-1 through the at2 receptor and prostaglandin e2: Implications for atherosclerotic plaque rupture J Leukoc Biol 78 2005 195 201 (Pubitemid 40979958)
21. M.E. Johansson, B. Fagerberg, and G. Bergstrom Angiotensin type 2 receptor is expressed in human atherosclerotic lesions J Renin Angiotensin Aldosterone Syst 9 2008 17 21 (Pubitemid 351546629)
22. Z.J. Cheng, H. Vapaatalo, and E. Mervaala Angiotensin ii and vascular inflammation Med Sci Monit 11 2005 RA194-RA205
23. M. Fukuhara, R.L. Geary, D.I. Diz, P.E. Gallagher, J.A. Wilson, and S.S. Glazier et al. Angiotensin-converting enzyme expression in human carotid artery atherosclerosis Hypertension 35 2000 353 359 (Pubitemid 30054199)
24. A. Okamura, H. Rakugi, M. Ohishi, Y. Yanagitani, S. Takiuchi, and K. Moriguchi et al. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages J Hypertens 17 1999 537 545 (Pubitemid 29308564)
25. Y. Dohi, M. Ohashi, M. Sugiyama, H. Takase, K. Sato, and R. Ueda Candesartan reduces oxidative stress and inflammation in patients with essential hypertension Hypertens Res 26 2003 691 697 (Pubitemid 37258655)
26. M. Tsuda, M. Iwai, J.M. Li, H.S. Li, L.J. Min, and A. Ide et al. Inhibitory effects of at1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress Hypertension 45 2005 545 551 (Pubitemid 40411257)
27. I.M. Larrayoz, T. Pang, J. Benicky, J. Pavel, E. Sanchez-Lemus, and J.M. Saavedra Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes J Hypertens 27 2009 2365 2376
28. A. Merino, M.A. Alvarez-Lara, R. Ramirez, J. Carracedo, A. Martin-Malo, and P. Aljama Losartan prevents the development of the pro-inflammatory monocytes cd14+cd16 + in haemodialysis patients Nephrol Dial Transplant 27 2012 2907 2912